These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21335937)

  • 21. [Influence of transforming growth factor beta1 on long-term renal allograft function].
    Wang PX; Fan MQ; Huang CB; Zhnag GF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1352-5. PubMed ID: 16982454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C4d complement split product in diagnosis of immunological activity of chronic allograft nephropathy.
    Mroz A; Lewandowski Z; Cieciura T; Matłosz B; Pazik J; Kwiatkowski A; Szmidt J; Durlik M
    Transplant Proc; 2006; 38(1):97-100. PubMed ID: 16504674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effect of sirolimus against chronic allograft nephropathy in kidney transplant recipients].
    Wang CX; Chen SY; Chen LZ; Liu LS; Fei JG; Deng SX; Qiu J; Li J; Zheng KL; Wu PG; Ji YL; Zhu LY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1924-6. PubMed ID: 18159022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model.
    Lutz J; Huang H; Deng M; Wagner B; Roos M; Schmaderer C; Strobl M; Heemann U
    Transplantation; 2007 Mar; 83(6):741-6. PubMed ID: 17414707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis and treatment of chronic allograft nephropathy with everolimus.
    Lutz J; Zou H; Liu S; Antus B; Heemann U
    Transplantation; 2003 Aug; 76(3):508-15. PubMed ID: 12923436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bailing capsule (
    Zhang Q; Xiao X; Li M; Yu M; Ping F
    Front Pharmacol; 2022; 13():915592. PubMed ID: 36091833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
    Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TGF-beta1 in allograft and long-term renal function].
    Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy].
    Liu S; Tang LQ; Chen LM; Chen XQ; Zhang ST; Wei Y
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):68-72. PubMed ID: 18338624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical, functional, and histologic response to heparin in chronic renal disease.
    Freedman P; Meister HP; De la Paz A; Ronaghy H
    Invest Urol; 1970 Mar; 7(5):398-409. PubMed ID: 5309575
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.
    Zhang YW; Xie D; Chen YX; Zhang HY; Xia ZX
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):563-8. PubMed ID: 17177138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of chronic allograft nephropathy.
    Nankivell BJ; Borrows RJ; Fung CL; O'Connell PJ; Allen RD; Chapman JR
    N Engl J Med; 2003 Dec; 349(24):2326-33. PubMed ID: 14668458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta 1 in renal allograft recipients.
    Coupes BM; Newstead CG; Short CD; Brenchley PE
    Transplantation; 1994 Jun; 57(12):1727-31. PubMed ID: 8016876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of silencing transforming growth factor-β1 by RNA interference plasmid on rat renal allograft fibrosis using Smads pathway.
    Yin Z; Xia Y; Luo C; Zhang J; He Y; Wu X
    Urology; 2011 Mar; 77(3):762.e1-7. PubMed ID: 21195468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
    Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
    Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
    Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ
    J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephro-protective effect of Kangqianling decoction on chronic renal failure rats.
    He L; Shen P; Fu Q; Li J; Dan M; Wang X; Jia W
    J Ethnopharmacol; 2009 Mar; 122(2):367-73. PubMed ID: 19146937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J; Taskinen E; Von Willebrand E
    Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M; Nitschke M; Weidtmann B; Jabs WJ; Wong W; Suefke S; Steinhoff J; Fricke L
    Transplantation; 2006 Apr; 81(7):1035-40. PubMed ID: 16612281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.